Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Central Nervous System Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Rhabdoid Tumor
National Cancer Institute (NCI)P2CCC (53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Skin Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Thyroid Gland Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Renal Pelvis/Ureter Urothelial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Wilms Tumor
National Cancer Institute (NCI)P2CCC (53)
Panitumumab
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Panitumumab
Female Reproductive Organ Cancer
National Cancer Institute (NCI)P2CCC (53)
Panitumumab
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Panitumumab
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2CCC (53)
pds01adc
Adrenal Cortex Neoplasm
National Cancer Institute (NCI)P2CCC (53)
pds01adc
Adrenal Gland Cancer
National Cancer Institute (NCI)P2CCC (53)
pds01adc
Adrenal Gland Neoplasm
National Cancer Institute (NCI)P2CCC (53)
pds01adc
Adrenal Cortex Carcinoma
National Cancer Institute (NCI)P2CCC (53)
pds01adc
Bile Duct Cancer
National Cancer Institute (NCI)P2CCC (53)
pds01adc
Bile Duct Neoplasm
National Cancer Institute (NCI)P2CCC (53)
pds01adc
Intrahepatic Bile Duct Cancer
National Cancer Institute (NCI)P2CCC (53)
pds01adc
Colorectal Cancer
National Cancer Institute (NCI)P2CCC (53)
Pegfilgrastim
Minimally Invasive Lung Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Pembrolizumab
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)P2CCC (53)
Pembrolizumab
Desmoplastic Melanoma
National Cancer Institute (NCI)P2CCC (53)
Pertuzumab
Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Pertuzumab
Cervical Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Pertuzumab
Carcinoma Of Esophagus
National Cancer Institute (NCI)P2CCC (53)
Showing 1926 to 1950 of 3,272 assets
PreviousPage 78 of 131Next